Novo Nordisk launches Wegovy in India, pricing it close to Eli Lilly’s Mounjaro, while advancing global regulatory efforts for its GLP-1 portfolio.
Novo’s India Move Could Reshape The Weight-Loss Drug War With Eli Lilly
Where Today's News Shapes Tomorrow
